PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportscholelithiasis
MeSH D002769 - cholelithiasis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001660:Biliary tract diseases
0 Companies
0 Drugs
Success rate
D002769: 
Cholelithiasis
$
Success rate
D041761:Cholecystolithiasis
0 Companies
0 Drugs
Success rate
D042882:Gallstones
0 Companies
0 Drugs
Success rate
D042883:Choledocholithiasis
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaUrsodiol Actigall  1987-12-31   
Ursodiol Ursodiol  2000-05-25   
Glenmark PharmaceuticalsUrsodiol Ursodiol  2011-07-12   
MylanUrsodiol Ursodiol  2010-02-17   
AllerganUrsodiol Urso  1997-12-10   
Aurobindo PharmaUrsodiol Ursodiol  2022-11-28   
Rising PharmaceuticalsUrsodiol Ursodiol  2020-02-12   
Zydus TherapeuticsUrsodiol Ursodiol  2018-10-30   
Amneal PharmaceuticalsUrsodiol Ursodiol  2018-10-16   
LannettUrsodiol Ursodiol  2008-12-15   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
0%
0/0
Phase 3
100%
4/4
Approved: 3Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use